Small Business Resources, Business Advice and Forms from AllBusiness.com

Cardima to Hold Third Quarter Results Conference Call October 25.

Business Editors

FREMONT, Calif.--(BUSINESS WIRE)--Oct. 19, 2001

Cardima(R), Inc. (Nasdaq:CRDM) today announced that the Company will release 2001 third quarter financial results after market close on Thursday, October 25, 2001. William Wheeler, president and chief operating

officer, and Ronald Bourquin, chief financial officer, will be hosting an investment-community conference call beginning at 4:30 p.m. Eastern Time on October 25, 2001 to discuss those results and to answer questions.

To participate in the live call via telephone, please call 800/540-0559. A telephone replay will be available for 48 hours by dialing 877/710-5302.

Individuals interested in listening to the conference call via the internet may do so by visiting the Company's website at www.cardima.com. A replay will be available on the website for 14 days.

Cardima, Inc. developed its patented, unique series of REVELATION microcatheter systems for the mapping and treatment of AF, which the Company believes is a potential $6 billion market that is poorly served by current treatment alternatives. AF afflicts an estimated 4.5 million people worldwide. The REVELATION series of microcatheters is a minimally invasive, single-use microcatheter for potentially curing AF. Cardima has a Phase III study underway in the U.S. for its Revelation Tx linear ablation microcatheter system. The Company believes enrollment in the Phase III trial will be completed at the end of calendar year 2001.

In addition, make sure to read these articles: